Keros Therapeutics Inc (KROS)

Equity Ratio

91.21%

Quarterly · Period ending:

KROS logo

KROS Equity Ratio

Latest reported91.21%
KROS Quarterly Equity Ratio (4.52% → 91.21%)
High-resolution chart · PNG

KROS equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Equity Ratio — Quarterly
Period endingEquity Ratio
91.21%
91.4622%
89.6785%
94.7221%
93.3395%
92.9018%
92.8018%
91.9837%
92.5045%
93.4395%
89.7812%
90.6804%
91.5674%
92.3389%
90.4303%
95.4365%
93.1823%
95.0464%
95.2686%
95.0061%
96.7941%
96.3691%
97.1341%
94.5836%
93.9663%
-41.0401%
4.5185%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.